Structured Evidence Transforms Target Selection at a Leading Pharma
How a global pharmaceutical company deployed Galactic Data across its discovery pipeline to improve portfolio value by hundreds of millions in expected NPV while cutting scholarship time by 72%.
Client
Large Pharma
Use Case
Target Selection & Evidence Prioritisation
Strategic Goal
Improve target confidence & reduce attrition risk
Time to ROI
Within 1 Year
+$246.5M
pipeline value protected
72%
reduction in manual curation time
40%
faster target shortlisting
+13.6%
improvement in trial success rate
From manual literature synthesis to evidence-scored target selection
Open each section to explore the challenge this client faced, how Galactic Data was deployed, and the measurable outcomes delivered.
The Challenge
The Solution
The Results
See what Galactic Data can do for your pipeline
We'll run a live analysis on your target of interest and show you the evidence in minutes.